The Dermatology Market in 2026

Dermatology is one of the steadier corners of healthcare to build a practice around. The US dermatology market was valued at roughly $552 million in 2025 and is projected to reach about $1.04 billion by 2034, a compound annual growth rate near 7.3% (Towards Healthcare, 2025). Demand is driven by chronic skin conditions such as acne, eczema, and psoriasis, an ageing population needing skin-cancer surveillance, and a cosmetic segment that keeps expanding even when discretionary spend tightens.

The harder number for a founder is the equipment market, because that is where capital concentrates. The US dermatology devices market generated about $6.33 billion in 2024 and is forecast to roughly double to $12.74 billion by 2030 (Grand View Research, 2024). That growth is concentrated in lasers, intense pulsed light, and energy-based body devices, the same line items that swing a clinic's startup budget from lean to heavy.

The split that matters most for planning is medical versus cosmetic. Cosmetic dermatology held the larger share, about 38.6% in 2024 (Market.us, 2025), and it behaves like a cash-pay retail business: higher revenue per provider, higher equipment and marketing cost, and far more sensitivity to local affluence. Medical dermatology behaves like an insurance business: steadier volume, lower per-visit value, and a result that lives or dies on coding accuracy and payer mix. A plan that blends the two into one margin number hides the very thing a lender or partner wants to understand.

One structural fact shapes the competitive picture: consolidation. Dermatology is among the most rolled-up physician specialties in the US, with more than 35 private-equity-backed platforms across roughly 20 states. Forefront Dermatology runs 200-plus clinics across 22 states under Partners Group; Schweiger Dermatology Group absorbed United Skin Specialists in 2024 and California Skin Institute in 2025; U.S. Dermatology Partners (Abry Partners), Anne Arundel Dermatology (Ridgemont Equity Partners), and Epiphany Dermatology (Leonard Green & Partners) round out a crowded acquirer field. For an independent founder this matters two ways: these groups set the local pay and pricing benchmarks you compete against, and they are also the most likely eventual buyer of a well-run clinic. A plan that names them reads as informed rather than generic.

Quick Answers Founders Ask

These are the questions that come up in nearly every first call about opening a clinic. Short answers here; the detail follows in the sections below.

How long does it take to open a dermatology clinic?

Six to twelve months in practice. The lease and buildout are predictable; the variable that blows timelines is payer credentialing, which commonly runs 90 to 150 days before you can bill an insured visit. Most founders start credentialing the day the entity and address are fixed, not after the fit-out.

Can I see patients before credentialing finishes?

You can see cash-pay cosmetic patients immediately, which is why many new clinics open cosmetic-first and switch on medical billing as enrolments clear. You cannot bill Medicare or commercial insurers for medical visits until credentialing completes.

Should I buy a laser on day one?

Usually not. Energy-based devices are the single largest discretionary line in the budget. The disciplined approach is to validate cosmetic demand in your catchment, often by leasing or offering a narrower menu first, then buy once utilisation justifies the depreciation.

Solo practice or join a group?

The PE platforms above pay for de-risked income and an exit, but they take the upside. Independent ownership keeps the upside and the cosmetic margin, at the cost of carrying the credentialing gap and equipment risk yourself. The business plan is where you prove the independent path pencils out.

Who Your Patients Actually Are

A dermatology business plan is stronger when it stops describing "patients" as one block and instead names the distinct people who walk through the door, because each group finds you differently, pays differently, and stays for different reasons. In practice a clinic serves at least four buyers, and the marketing budget and clinical schedule should be built around the mix you actually expect rather than an average.

• Insured medical patients: people with acne, eczema, psoriasis, suspicious moles, or a referral for skin-cancer surveillance. They arrive through primary-care referral and search, value access and reassurance, and are billed to insurance at roughly $150 per encounter.
• Recurring chronic patients: the same medical patients on long-term management plans. They are the predictable backbone of the schedule and the easiest revenue to forecast because their visit cadence is known.
• Cosmetic cash-pay patients: typically a more affluent 35 to 60 demographic seeking neuromodulators, fillers, IPL, and skin resurfacing. They choose on reputation and results, pay out of pocket, and carry the highest per-visit value.
• Retail and membership buyers: medical-grade skincare customers and members on a recurring cosmetic plan. This is the highest-margin, lowest-clinical-time revenue in the practice and is almost always under-modelled.

The plan should quantify how large each group is in your catchment, how quickly each converts, and which one you can reach most efficiently. Insured medical demand is reached through referral relationships and local search; cosmetic demand is reached through paid social, reputation, and word of mouth among an affluent network. A clinic that tries to serve all four with one undifferentiated message tends to spend too much acquiring the cheapest patients and too little nurturing the most valuable ones. Mapping the segments is also what lets you defend a pricing strategy: cosmetic prices are anchored to outcome and scarcity, not to the reimbursement schedule that governs medical visits.

For most independent launches, the smart opening posture is cosmetic-weighted demand generation paired with a steadily building medical referral base. The cosmetic side produces cash while credentialing clears, and the medical side compounds into the stable, fundable income that a lender or an eventual acquirer cares about.

What It Costs to Open

A lean single-provider medical clinic can open for around $150,000. A full cosmetic build with lasers, IPL, and a fitted treatment suite typically lands between $350,000 and $600,000, and at the top end a multi-room cosmetic flagship can pass $2.5 million. In the UK the comparable range runs roughly £90,000 to £450,000. The spread is almost entirely a function of three choices: how much buildout you take on, how much energy-based equipment you buy up front, and how many months of working capital you reserve for the credentialing gap.

Cost Breakdown

• Facility lease deposit + clinical buildout: $50K–$250K (£40K–£190K), the biggest single variable; existing medical space cuts this sharply
• Equipment + lasers (dermatoscopes, IPL, CO2/Nd:YAG): $40K–$200K (£32K–£155K), defer the heavy devices until demand is proven
• EHR / practice-management software + setup: $8K–$30K (£6K–£24K), dermatology-specific platforms speed coding and image capture
• Licensing, credentialing support + professional indemnity: $10K–$45K (£8K–£36K)
• Initial staffing + recruitment (PA, RN, aesthetician): $25K–$90K (£20K–£70K)
• Working capital (credentialing lag, 3–6 months): $30K–$120K (£24K–£95K), the line most plans underfund

Note how the equipment and working-capital lines move together. The more cosmetic you go, the heavier the device spend, but cosmetic is cash-pay, so it shortens the time to first revenue. The more medical you go, the lighter the equipment, but the longer you wait on credentialing, so the working-capital reserve has to grow. The template forces you to size both at once rather than treating them as separate guesses.

The headline range hides three very different starting points, and a credible plan should declare which one it is modelling. A medical-only solo clinic taking over existing physician space can genuinely open near the $150,000 floor, because the buildout is light and the device spend is minimal. A balanced medical-and-cosmetic clinic with a starter laser and IPL package, two or three treatment rooms, and a few months of reserve typically lands in the $350,000 to $600,000 band that most of this guide is built around. A cosmetic flagship with multiple energy platforms, a designed retail and treatment experience, and a second provider from day one is where budgets push past a million and, at the extreme, beyond $2.5 million.

Founders also routinely underweight the soft costs that do not buy a physical asset: legal and entity setup, the credentialing service that shortens the reimbursement wait, recruiting fees for hard-to-fill clinical roles, and the marketing spend needed to fill the schedule before word of mouth takes over. Adding a 10% to 15% contingency on top of the line items is standard discipline, and a plan that shows one signals to a lender that the founder has built a budget before, not just a wish list.

SBA Financing for NAICS 621111

Dermatology practices are classified under NAICS 621111, Offices of Physicians (except Mental Health Specialists), which is squarely eligible for the most common US small-business financing route. The SBA 7(a) programme funds practice startup, acquisition, equipment, and working capital up to $5 million, with repayment terms of 5 to 25 years (SBA7a.loans, 2026).

• Guarantee structure: the SBA backs up to 85% of loans at or under $150K and 75% above $150K, which is why lenders treat clean physician practices as low-risk paper
• Faster lane for smaller asks: SBA Express returns a decision in around 36 hours for needs under $500K, useful for equipment-only financing
• What lenders expect: a full five-year forecast (income statement, cash flow, balance sheet) alongside the narrative, not just a story
• Common dermatology use: bridging the credentialing gap with working capital and financing the laser/IPL package without draining personal reserves

The practical takeaway is that the plan and the forecast are the loan application. A dermatology raise that separates medical and cosmetic projections, shows the credentialing-lag cash dip explicitly, and ties the ask to a named NAICS code clears underwriting faster than a single blended projection. Our bespoke plan service formats the forecast to that standard.

Location, Catchment, and Build Decisions

Location does more work in dermatology than in most service businesses because it sets both halves of the revenue model at once. The medical side depends on referral density and insured-population reach, while the cosmetic side depends almost entirely on local affluence and visibility. A site that is excellent for one can be mediocre for the other, so the plan should state plainly which side it is optimising for and why.

Rent in major US metros commonly runs $2,000 to $8,000 per month for clinical-grade space, and renovation to medical standard can range from $50,000 to $250,000 depending on the number of treatment rooms, plumbing for procedure suites, and the electrical load energy-based devices require. Taking over existing medical space, a former dental or physician office, is the single most reliable way to compress that buildout figure, because the bones (sinks, dedicated power, accessible layout) are already in place.

• Referral catchment: count primary-care offices, urgent-care centres, and competing dermatology groups within a realistic drive time, since medical volume follows referral relationships
• Affluence and visibility: for the cosmetic line, proximity to higher-income postcodes and signage visibility matter more than referral density
• Competitive overhang: if a PE-backed group already saturates the area, plan to win on responsiveness and specialist focus rather than head-on price
• Build path: existing medical space, a clinical fit-out of retail space, or new build, in ascending order of cost and timeline
• Power and plumbing: lasers and IPL need dedicated electrical capacity; confirm it before signing, as retrofitting is expensive

The location section is also where a lender looks for evidence that you have validated demand rather than assumed it. A plan that cites the actual number of competing providers in the catchment, the local insured population, and a defensible estimate of cosmetic spend reads as researched. One that says the area is "growing" reads as a guess, and underwriters discount guesses.

Staffing and Clinical Workflow

Payroll is the largest recurring cost in a dermatology practice, which is why the staffing model is where margin is won or lost. A common Year-1 build for a growing clinic is one or two dermatologists, a physician assistant or nurse practitioner to extend medical capacity, registered nurses, a medical aesthetician for cosmetic services, and a laser technician where energy devices are in use. Front-office staff handle scheduling, intake, and the billing and credentialing workflow that quietly determines whether insured revenue actually lands.

The economics behind those salaries are worth stating in the plan. The mean annual wage for a dermatologist is about $347,810 per US Bureau of Labor Statistics data, while owner-operators and high-procedure practices commonly clear $426,000 at the median and $650,000-plus at the top end once ownership and procedural income are counted (U.S. Bureau of Labor Statistics, 2025). Mid-level providers and aestheticians cost far less per hour and are the primary lever for expanding capacity without adding a second physician, which is exactly the move that lifts revenue per provider toward the cosmetic-side $1.8 million figure.

Workflow design matters as much as headcount. The highest-leverage clinics protect physician time for the work only a physician can bill, push appropriate visits to mid-level providers, and route cosmetic consultations to staff whose time is cheaper than a dermatologist's. The plan should show a clinical-workflow diagram or at least a written sequence, because investors read it as a proxy for whether the founder understands throughput, not just medicine.

Medical vs Cosmetic Economics

A dermatology practice is really two businesses sharing a waiting room. Medical dermatology collects roughly $150 per insured encounter and runs on reimbursement, so the levers are visit volume, coding accuracy, and payer mix. Cosmetic dermatology is cash-pay: a first cosmetic visit often runs about $500, and a new cosmetic patient is worth $1,000 to $1,500 in year one once repeat treatments are counted.

At the practice level, those differences compound. Revenue per full-time provider averages roughly $1.3 million for medical dermatology and $1.8 million for cosmetic, while operating expenses run about 72.9% of net revenue on the medical side and 75.1% on the cosmetic side, leaving net margins in the 24% to 27% band and a sector-wide range of 20% to 40% depending on procedure mix (FOCUS, 2025). Cosmetic earns more per provider but spends more to do it; the margin gap is narrower than the revenue gap, which is exactly the nuance a blended model erases.

A worked example

Take a two-provider clinic running about 60% capacity in its first year. A realistic gross is in the order of $290,000 per month at that utilisation, against fixed overhead near $16,000 a month before payroll. The tell-tale feature is the cash curve: with credentialing lagging, a model like this can dip to its lowest cash point in month two, sometimes by several hundred thousand dollars, before insured revenue catches up. That dip, not the headline revenue, is what the SBA reserve and the cosmetic-first opening are designed to cover.

Secondary revenue lines layer on top once the core is stable: medical-grade skincare retail, membership plans for cosmetic patients, in-house pathology for biopsies, and Mohs surgery referrals if you build the capability. A serious plan models each as its own line with its own margin, because each behaves differently from the base medical visit.

One number quietly governs whether the medical side hits its projection: the net collection rate, the share of contracted revenue you actually collect after denials, write-offs, and underpayments. Strong dermatology practices run net collection in the high 90s; a clinic leaking five or six points there is giving away most of its margin without noticing. The financial model should treat collection rate as an explicit assumption, not bury it inside a single revenue figure, because it is the difference between a plan that survives contact with real billing and one that does not.

Marketing Two Audiences at Once

Dermatology marketing fails when it treats medical and cosmetic patients as the same audience, because they are reached through almost opposite channels. Medical demand is earned slowly through referral relationships and local search intent; cosmetic demand is bought and amplified through reputation, visuals, and paid reach. The plan should budget for both, with different metrics for each.

Medical-side acquisition

The medical side compounds through primary-care and urgent-care referral relationships, accurate local listings, and search visibility for conditions and procedures. The cost per acquired patient is low once relationships are built, but it takes months to build them, which is why the plan should fund a slow, relationship-led medical channel rather than expecting paid ads to carry it.

Cosmetic-side acquisition

Cosmetic patients respond to results, social proof, and visible expertise. Before-and-after galleries, membership offers, and a credible online reputation move the needle far more than a generic ad. Because the first-visit value is around $500 and year-one value runs to $1,500, the practice can afford a meaningfully higher acquisition cost here than on the medical side, and the plan should say so explicitly so the marketing budget is not spread evenly across two channels with very different economics.

The technology and EHR stack

A dermatology-specific electronic health record and practice-management platform is not optional infrastructure; it is a revenue tool. The right system speeds dermatology-specific coding, captures lesion imaging, automates recalls for chronic patients, and tightens the billing workflow that protects the net collection rate. Online scheduling, automated review requests, and membership-management tooling round out a stack that lets a lean front office punch above its headcount. Budget $8,000 to $30,000 for software and setup, and treat the recall and reputation automations as the parts that pay for themselves.

Licensing Across Three Markets

Dermatology sits at the intersection of medical regulation and, for cosmetic work, a newer cosmetic-procedure regime. The requirements differ sharply by country, and the cosmetic side is where the rules are changing fastest.

United States

• State medical license and board certification through the American Board of Dermatology ($500–$1,500 per license; 2–6 months)
• Payer credentialing with Medicare and commercial insurers via CAQH, 90 to 150 days and the primary launch bottleneck; often outsourced for $3K–$8K
• DEA registration plus any state controlled-substance registration for prescribing (~$888 over three years)
• Facility, OSHA, and HIPAA compliance, plus state rules on who may operate energy-based cosmetic devices

United Kingdom

• Register the regulated medical activity with the Care Quality Commission (CQC), typically 10–14 weeks
• GMC registration with appropriate medical indemnity in place before treating patients
• From the 2025 England licensing scheme, a local-authority licence for non-surgical cosmetic procedures in the green and amber risk tiers; higher-risk red-tier procedures remain restricted to CQC-registered premises (GOV.UK, 2025)
• Premises hygiene, infection control, sharps disposal, and a fire risk assessment

Australia (and a Canada note)

• AHPRA registration for the practitioner, plus state radiation-use licensing for certain laser and IPL devices
• TGA advertising rules now restrict how cosmetic injectables can be promoted to the public
• In Canada, provincial College of Physicians and Surgeons licensure applies, and in Ontario in-clinic procedures may fall under out-of-hospital premises inspection (CPSO OHPIP)

For deeper cosmetic-specific licensing, our related guides on the aesthetic clinic business plan and the botox clinic business plan go further into the green/amber/red tiering.

Mistakes That Sink New Clinics

Across dermatology launches, the same avoidable errors recur. Each one is a place where the business plan should already have an answer.

• Underfunding the credentialing gap. The 90–150 day wait for insured reimbursement is the most common reason a clinic runs out of cash in month two. Size the working-capital reserve to that gap, not to the lease.
• Buying lasers before validating demand. Energy-based devices are the heaviest discretionary spend. Buy once utilisation justifies the depreciation, not on opening day.
• Modeling one blended margin. Medical and cosmetic have different revenue per provider, different cost structures, and different cash timing. A single line hides the risk underwriters look for.
• Treating CQC as the whole UK picture. The 2025 England cosmetic-licensing scheme adds a local-authority layer on top of CQC for non-surgical procedures. Missing it stalls the cosmetic launch.
• Pricing cosmetic against medical collections. Anchoring cosmetic prices to the ~$150 medical encounter leaves cash on the table; cosmetic first visits support $500-plus and far higher first-year value.

A Realistic 6 to 12 Month Launch Timeline

Dermatology launches run long because two slow processes, credentialing and buildout, have to finish before insured revenue flows, and they do not parallelise neatly. Sequencing them well is the difference between opening on plan and burning three extra months of working capital. The order below is the one we use when building bespoke plans.

• Months 1 to 2: incorporate the entity, secure the site and lease, and start payer credentialing immediately, because it is the longest pole in the tent. Begin CQC or state-board registration in parallel.
• Months 2 to 4: design and begin the clinical buildout, order EHR and long-lead equipment, and finalise the cosmetic device package only after demand is validated.
• Months 4 to 6: recruit and onboard clinical and front-office staff, configure the billing and recall workflow, and build the marketing engine for both audiences.
• Months 5 to 7: open cosmetic-first on cash-pay revenue while medical credentialing clears, keeping the schedule weighted to the services you can bill today.
• Months 6 to 12: switch on insured medical billing as enrolments complete, ramp the referral base, and drive toward the capacity assumptions in the forecast.

The plan should attach a cash-flow projection to this timeline so the lowest cash point, typically around month two, is visible rather than implied. That single chart does more to win a lender's confidence than any amount of narrative, because it shows you have already found the hole the money is meant to fill.

Dermatology Business Terms Worth Knowing

A short glossary so the plan, and your conversations with lenders and landlords, use the same vocabulary they do.

• Credentialing: the payer process that authorises a provider to bill Medicare and commercial insurers. It commonly takes 90 to 150 days and gates all insured revenue.
• Net collection rate: the share of contracted revenue actually collected after denials and write-offs. Strong dermatology practices run in the high 90s.
• NAICS 621111: the industry code for Offices of Physicians (except Mental Health Specialists), the classification a dermatology practice uses for SBA financing.
• Mohs surgery: a precise, staged technique for removing skin cancer that, when offered in-house, adds a high-value medical revenue line.
• Energy-based devices: lasers, IPL, and radiofrequency equipment used in cosmetic work; the heaviest discretionary line in a startup budget.
• MSO / PE platform: a management services organisation or private-equity-backed group that consolidates practices, sets local benchmarks, and is a likely eventual buyer.
• Revenue per provider: annual revenue divided by full-time clinicians, roughly $1.3M medical and $1.8M cosmetic; the headline efficiency metric acquirers watch.

Sample Business Plan Preview

Here's an extract from a dermatology business plan written by our team, so you can see exactly what you'll get:

What's in the Template

Every Avvale business plan template includes these sections, pre-structured for a dermatology practice:

• Executive Summary, your clinic at a glance, written to hold a lender's attention in 60 seconds
• Company Overview, legal structure, ownership, location, and the medical/cosmetic split
• Industry Analysis, market size, device-market growth, and the consolidation backdrop
• Patient & Customer Analysis, insured vs cash-pay segments and their buying triggers
• Competitor Analysis, local independents, PE-backed groups, and med-spa substitutes
• Marketing Plan, referral pathways for medical, paid and reputation channels for cosmetic
• Operations Plan, credentialing timeline, staffing, clinical workflow, device utilisation
• Management Team, founder credentials, advisory board, and planned hires

The optional Financial Forecast add-on (included in our $300/£250 and $1,000/£800 packages) provides a 5-year Excel model with separate medical and cosmetic revenue lines, a cash-flow view that exposes the credentialing dip, income statement, balance sheet, break-even, and startup capital requirements formatted for SBA review. You can also start from our free business plan templates or the market research and content service.

What separates this dermatology template from the generic "write a plan in nine steps" content that fills the search results is that the structure is built around the two decisions that actually determine whether a clinic survives its first year: the medical-versus-cosmetic mix and the working-capital reserve that bridges credentialing. Most operators stop at a single revenue figure and a single margin. The number that actually drives this business is revenue per provider split by service line, paired with a net collection rate you can defend. The template prompts for both, so the plan you hand a lender answers the question they were going to ask anyway.

Frequently Asked Questions